Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2026 ,inter alia, to consider and approve the proposal for raising of ....
ZIMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zim Laboratories has informed stock exchanges that its Board of Directors will meet on 21 January 2026 to consider raising funds. The proposal could include issuing equity shares, warrants, securities convertible into equity, or debt securities. The fund-raising may be done through a rights issue, preferential allotment on private placement, qualified institutional placement (QIP), or any combination of these methods, subject to shareholder and regulatory approvals. The Board may also convene an extraordinary general meeting or postal ballot to seek shareholder approval. Separately, the trading window for insiders is closed from 1 January 2026 until 48 hours after the declaration of Q3 FY26 financial results.
The announcement signals that a potential equity dilution or capital infusion is on the table, but no size, price, or method has been confirmed yet. Shareholders should watch for the post-Board update on 21 January 2026 for clarity on the instrument and amount, which could affect short-term share price sentiment.